melatonin has been researched along with guaifenesin in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ahn, KS; Jeon, CM; Kim, JC; Kim, JS; Kwon, OK; Oh, SR; Park, JW; Shin, IS; Shin, NR | 1 |
Ahn, KS; Hong, JM; Jeon, CM; Kim, JC; Kim, JS; Kwon, OK; Lee, IC; Oh, SR; Park, JW; Shin, IS; Shin, NR | 1 |
2 other study(ies) available for melatonin and guaifenesin
Article | Year |
---|---|
Melatonin reduces airway inflammation in ovalbumin-induced asthma.
Topics: Animals; Antibody Formation; Asthma; Bronchoalveolar Lavage Fluid; Cell Line; Cytokines; Disease Models, Animal; Enzyme Activation; Female; Immunoglobulin E; Inflammation; Inflammation Mediators; Matrix Metalloproteinase 9; Melatonin; Mucus; Ovalbumin; Tumor Necrosis Factor-alpha | 2014 |
Melatonin attenuates neutrophil inflammation and mucus secretion in cigarette smoke-induced chronic obstructive pulmonary diseases via the suppression of Erk-Sp1 signaling.
Topics: Animals; Antioxidants; Cell Line, Tumor; Disease Models, Animal; Extracellular Signal-Regulated MAP Kinases; Humans; Inflammation; Lipopolysaccharides; Male; MAP Kinase Signaling System; Melatonin; Mice; Mucus; Neutrophil Infiltration; Neutrophils; Pulmonary Disease, Chronic Obstructive; Rats; Smoking; Sp1 Transcription Factor | 2015 |